Find patient medical information for Lamisil oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Lamisil tablets should be immediately discontinued in case of elevation of liver function test. Very rare cases of serious liver failure (some with a fatal outcome, or requiring liver transplant) have been reported in patients treated with Lamisil tablets. In the majority of liver failure cases the patients had serious underlying systemic conditions (see sections 4.3 Contraindications and 4.8. Lamisil tablets are used to treat infections caused by fungus that affect the fingernails or toenails. Lamisil oral granules are used to treat a fungal infection of scalp hair follicles in children who are at least 4 years old, though this medication is no longer available in the United States. Warnings. Some people taking Lamisil have developed severe liver damage leading to liver transplant. Lamisil Tablets are used to treat a number of fungal infections of the skin and nails. 2. Things to consider before you start to take Lamisil Tablets Some people MUST NOT take Lamisil Tablets. Talk to your doctor if: you think you may be allergic to terbinafine or to any of the other ingredients of Lamisil Tablets. (These are listed in Section 6.) you have or have had any liver problems you. Lamisil tablets do not contain lactose, sucrose, gluten, tartrazine, or any other azo dyes. Dose advice: How to use Lamisil Tablets Before you take Lamisil tablets When you must not take it. Do not take Lamisil if you have ever had an allergic reaction to: Terbinafine, the active ingredient, or to any of the other ingredients listed here; Any other medicines, foods, preservatives or dyes. Your. LAMISIL® Tablets and these changes has not been established. Terbinafine clearance is increased 100% by rifampin, a CyP450 enzyme inducer, and decreased 33% by cimetidine, a CyP450 enzyme. LAMISIL 250 mg : comprimé sécable (blanc) ; boîte de 28 Sur ordonnance (Liste II) - Remboursable à 65 % - Prix : 22,64 €. Les prix mentionnés ne tiennent pas compte des « honoraires de dispensation » du pharmacien. Lamisil Tablets should be discontinued in patients with clinical signs and symptoms suggestive of lupus erythematosus. Thrombotic Microangiopathy. Cases of thrombotic microangiopathy (TMA), including thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, some fatal, have been reported with terbinafine. Discontinue terbinafine if clinical symptoms and laboratory findings consistent. Lamisil tablets are white to yellow- tinged, round tablets with LAMISIL 250 in a circular pattern on one side and a break line on the reverse side. Lamisil tablets are available in blister packs of 42 tablets. Ingredients. Active Ingredient. Lamisil tablets contain 250 mg terbinafine (as the hydrochloride salt) per tablet. Inactive ingredients INDICATIONS. Lamisil (terbinafine hydrochloride) Tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis.